Xiaolin Wang
- Genetics top 5%
- Hematology top 5%
- Oncology top 10%
- Colorectal Cancer Surgical Treatments 12
- Colorectal Cancer Screening and Detection 12
- Cancer Cells and Metastasis 6
- Colorectal Cancer Treatments and Studies 5
-
- Gastric Cancer Management and Outcomes 9
-
- Colorectal and Anal Carcinomas 6
-
- Epigenetics and DNA Methylation 6
-
- Genetic factors in colorectal cancer 5
- Co-authors
- Huichuan YuYanxin LuoAyalew TefferiKebede H. BegnaTerra L. LashoCurtis A. HansonMrinal M. PatnaikDarci Zblewski
- Cited by
- GeneticsHematologyOncology
- Partner nations
- ChinaUnited StatesSouth Sudan
In The Last Decade
Xiaolin Wang
99 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Genetics 216
- Hematology 169
- Oncology 365
- Aging 18
- Cancer Research 152
Countries citing papers authored by Xiaolin Wang
This map shows the geographic impact of Xiaolin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolin Wang more than expected).
Fields of papers citing papers by Xiaolin Wang
This network shows the impact of papers produced by Xiaolin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolin Wang. The network helps show where Xiaolin Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaolin Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 1 | |
| 7 | 2020 | 15 | |
| 8 | hsa_circRNA_101237: A Novel Diagnostic and Prognostic Biomarker and Potential Therapeutic Target for Multiple Myeloma | 2020 | 2 |
| 9 | 2020 | 5 | |
| 10 | 2020 | 18 | |
| 11 | Inhibition of KPNB1 Inhibits Proliferation and Promotes Apoptosis of Chronic Myeloid Leukemia Cells Through Regulation of E2F1 | 2019 | 1 |
| 12 | [Pediatric colonoscopy in South China: a single-center experience from 229 cases]. | 2017 | 4 |
| 13 | 2014 | 9 | |
| 14 | 2013 | 1 | |
| 15 | 2012 | 1 | |
| 16 | 2012 | 36 | |
| 17 | 2011 | 1 | |
| 18 | The Clinical Observation of Advanced Non small Cell Lung Cancer Treated with ShenMai Injection Combined with the Chemotherapy | 2010 | 1 |
| 19 | Recombinant Ganoderma Lucidum immunoregulatory protein (rLZ-8) induces nuclear-stress apoptosis in K562 cells | 2010 | 4 |
| 20 | 2010 | 20 |
About Xiaolin Wang
Xiaolin Wang is a scholar working on Oncology, Pathology and Forensic Medicine and Genetics, having authored 106 papers that have together received 1.5k indexed citations. Recurring topics across this work include Colorectal Cancer Surgical Treatments (12 papers), Colorectal Cancer Screening and Detection (12 papers), Gastric Cancer Management and Outcomes (9 papers), Colorectal and Anal Carcinomas (6 papers), Cancer Cells and Metastasis (6 papers), Epigenetics and DNA Methylation (6 papers), Genetic factors in colorectal cancer (5 papers) and Colorectal Cancer Treatments and Studies (5 papers). The work is most often cited by research in Genetics (216 citations), Hematology (169 citations) and Oncology (365 citations). Xiaolin Wang has collaborated with scholars based in China, United States and South Sudan. Frequent co-authors include Huichuan Yu, Yanxin Luo, Ayalew Tefferi, Kebede H. Begna, Terra L. Lasho, Curtis A. Hanson, Mrinal M. Patnaik, Darci Zblewski, Animesh Pardanani and Emnet A Wassie. Their work appears in journals such as Medicine, Cancer Medicine, Scientific Reports, Cancer Research and Journal of Orthopaedic Research®.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.